Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Beta-blockers do not benefit heart attack patients with a normal LVEF
The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.
Oral heart failure drug receives FDA’s fast track designation
A clinical trial focused on patients with HFpEF is expected to be completed by July 2026.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]

New-look TAVR valve recently acquired by Edwards may reduce risk of coronary obstruction

Early data suggest the J-Valve transcatheter heart valve could help care teams avoid a rare, but often fatal TAVR complication when treating high-risk patients.

cardiologists evaluating the human heart to provide a treatment strategy

Rising heart failure, AFib rates a ‘wake-up call’ for US cardiologists

Today's heart teams already face a number of challenges on a day-to-day basis. New data suggest they could soon be treating more patients than ever before.

Novel imaging technique could be used to tailor glioblastoma treatment

It allows providers to quantify changes in tumor size throughout patients’ treatment in real-time, providing early indications of efficacy and enabling adjustments as needed.

Post-mastectomy radiation therapy can be safely shortened prior to breast reconstruction

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road.

Medtronic has launched VitalFlow, a new all-in-one extracorporeal membrane oxygenation (ECMO) system designed to provide clinicians with a user-friendly experience. According to Medtronic, its goal with the VitalFlow system was to develop a simple, straightforward ECMO device that helps clinicians by making everything as intuitive as possible.

Medtronic launches new all-in-one ECMO system after acquiring longtime partner

According to Medtronic, its goal was to develop a user-friendly ECMO device that makes patient care as intuitive as possible.

Endotronix, an Illinois-based healthcare technology company, has gained U.S. Food and Drug Administration approval for its Cordella Pulmonary Artery (PA) Sensor System, which uses PA pressure-guided therapy to manage and treat heart failure patients.

Implantable PA sensor for heart failure linked to positive 1-year outcomes

The new Cordella device from Endotronix, now an Edwards Lifesciences company, uses an implantable device to track the patient's pulmonary artery pressure and other helpful health data.

FDA clears new device for valve-in-valve TAVR patients at risk of coronary obstruction

ShortCut, which gained the FDA’s breakthrough device designation back in January, is used to split valve leaflets and reduce the risk of obstruction.

With AFib ablation on the rise, HRS highlights importance of proper EP training

Cardiac ablation techniques and technologies are constantly evolving. Only well-trained specialists should be performing these procedures, the Heart Rhythm Society said in a new policy statement.

Clinical

Beta-blockers do not benefit heart attack patients with a normal LVEF

Oral heart failure drug receives FDA’s fast track designation

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

Drones deliver AEDs for the first time in the United States